Howe & Rusling Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Howe & Rusling Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $408 - $594	7 Added 100.0%	14 $1,000
Q2 2021 Aug 13, 2021	SELL	$62.15 - $90.32 $186 - $270	-3 Reduced 30.0%	7 $1,000
Q1 2021 May 13, 2021	SELL	$61.35 - $90.47 $3,619 - $5,337	-59 Reduced 85.51%	10 $1,000
Q4 2020 Feb 08, 2021	BUY	$43.82 - $85.37 $832 - $1,622	19 Added 38.0%	69 $5,000
Q3 2020 Nov 06, 2020	BUY	$33.21 - $51.27 $1,660 - $2,563	50 New	50 $2,000
Q2 2020 Jul 15, 2020	SELL	$26.12 - $43.27 $626 - $1,038	-24 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$20.56 - $63.12 $493 - $1,514	24 New	24 $1,000

304

95.8M

523K

493K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.56B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.